NFE2L2 and breast carcinoma: A previous study found that enhanced Nrf2/HO-1 signaling may contribute to breast cancer progression, and miR-140-5p could be a strategy for nuclear factor erythroid 2-related factor 2 (Nrf2)-driven cancer progression [46].